Adults with Asthma Breathe Easier
New Treatment for Severe Asthma
Our Lung Center is the first in New Jersey to offer a new FDA-approved
treatment for adults with severe and persistent asthma. Known as bronchial
thermoplasty, this outpatient treatment reduces the ability of the airway
to constrict, thereby reducing the frequency and severity of asthma attacks.
Bronchial thermoplasty is the first FDA-approved non-pharmaceutical asthma
treatment. “It results in fewer asthma attacks, fewer visits to
the Emergency Department and a reduction in the number of hospitalizations
due to asthma. Research studies have shown that these respiratory improvements
are sustained for at least two years following the treatment.”
The procedure delivers precisely controlled thermal energy to the airway
wall to reduce excessive airway smooth muscle and its ability to constrict.
The complete treatment is delivered in three sessions over a period of
about nine weeks. Many patients notice a significant improvement following
the first treatment.
Once treatment is complete, patients return to their primary physician,
allergist or their referring pulmonologist for continued care. The procedure
is covered by Medicare and Medicaid as well as many private health insurance agencies.
The Lung Center has offices at Newark Beth Israel Medical Center, Saint
Barnabas Medical Center in Livingston, Monmouth Medical Center in Long
Branch, and the Heart and Lung Specialty Center in Toms River.For more information about bronchial thermoplasty or to schedule an evaluation,
please call the Lung Center at 973-926-4430 or 1-888-NJ-Lung-1.